These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 7872957)
1. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist. Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957 [TBL] [Abstract][Full Text] [Related]
2. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists. Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706 [TBL] [Abstract][Full Text] [Related]
3. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. Lau LF; Pumiglia K; Côté YP; Feinstein MB Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841 [TBL] [Abstract][Full Text] [Related]
4. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. Vassallo RR; Kieber-Emmons T; Cichowski K; Brass LF J Biol Chem; 1992 Mar; 267(9):6081-5. PubMed ID: 1313429 [TBL] [Abstract][Full Text] [Related]
5. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist. Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442 [TBL] [Abstract][Full Text] [Related]
6. Development of potent thrombin receptor antagonist peptides. Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546 [TBL] [Abstract][Full Text] [Related]
7. Involvement of the "tethered-ligand" receptor in thrombin inhibition of platelet adenylate cyclase. Seiler SM; Michel IM; Fenton JW Biochem Biophys Res Commun; 1992 Feb; 182(3):1296-302. PubMed ID: 1371679 [TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling. Schwemmer M; Sommer O; Bassenge E Cardiovasc Drugs Ther; 2001 Jul; 15(4):301-7. PubMed ID: 11800413 [TBL] [Abstract][Full Text] [Related]
10. A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets. Rasmussen UB; Gachet C; Schlesinger Y; Hanau D; Ohlmann P; Van Obberghen-Schilling E; Pouysségur J; Cazenave JP; Pavirani A J Biol Chem; 1993 Jul; 268(19):14322-8. PubMed ID: 8390990 [TBL] [Abstract][Full Text] [Related]
11. Evidence that Na+/H+ exchange regulates receptor-mediated phospholipase A2 activation in human platelets. Sweatt JD; Connolly TM; Cragoe EJ; Limbird LE J Biol Chem; 1986 Jul; 261(19):8667-73. PubMed ID: 3013859 [TBL] [Abstract][Full Text] [Related]
12. A comparative SAR study of thrombin receptor derived non peptide mimetics: importance of phenyl/guanidino proximity for activity. Alexopoulos K; Matsoukas J; Tselios T; Roumelioti P; Mavromoustakos T; Holada K Amino Acids; 1998; 15(3):211-20. PubMed ID: 9871500 [TBL] [Abstract][Full Text] [Related]
13. Thrombin receptor-mediated vascular relaxation differentiated by a receptor antagonist and desensitization. Tesfamariam B Am J Physiol; 1994 Nov; 267(5 Pt 2):H1962-7. PubMed ID: 7526715 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets. Matsuoka I; Nakahata N; Nakanishi H Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation. Burke FM; Warnock M; Schmaier AH; Mosberg HI Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. Ahn HS; Foster C; Boykow G; Stamford A; Manna M; Graziano M Biochem Pharmacol; 2000 Nov; 60(10):1425-34. PubMed ID: 11020444 [TBL] [Abstract][Full Text] [Related]
17. Interaction of the protein C activation peptide with platelets. Martínez-Cruz R; Canseco Mdel S; Lopez-Martínez J; Cruz PA; Pérez-Campos E; Cruz MM; Alva FC; Majluf-Cruz A; Zenteno E; Ruiz-Argüelles A Prep Biochem Biotechnol; 2007; 37(2):139-47. PubMed ID: 17454824 [TBL] [Abstract][Full Text] [Related]
18. No direct correlation between Ca2+ mobilization and dissociation of Gi during platelet phospholipase A2 activation. Crouch MF; Lapetina EG Biochem Biophys Res Commun; 1988 May; 153(1):21-30. PubMed ID: 3132162 [TBL] [Abstract][Full Text] [Related]
19. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen. Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683 [TBL] [Abstract][Full Text] [Related]
20. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis. Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]